Illumina, Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
6.9
Neutral
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
ILMN
High-quality business with 34% return on equity and 19% profit margins.
⚠ analyst sentiment is cautious.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $138.94 (+2.3%)
17 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
ILMN
PFE
24.7×
Trailing P/E
19.4×
23.0×
Forward P/E
9.4×
19.4%
Profit Margin
12.4%
68.4%
Gross Margin
75.8%
33.8%
ROE
8.9%
4.8%
Revenue Growth
-1.2%
6.1%
Earnings Growth
—
1.49
Beta
0.39
—
Price / Book
—
$20.6B
Market Cap
$149.8B
$74 – $156
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →